News
Doctors say there have been a number of developments with new weight loss drugs, which could make them easier for patients to ...
The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more ...
Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...
Shares of Novo Nordisk (NYSE: NVO) are tumbling on Monday, down 5.6% as of 2:11 p.m. ET. The drop comes as the S&P 500 ...
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
Amgen's experimental drug MariTide shows potential for significant weight loss in obese patients, despite notable side ...
The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a collaboration.
Amgen shares fell sharply on Monday afternoon after the company released results from a weight-loss trial that showed that ...
Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...
Discover how appetite suppressants like psyllium and glucomannan, as well as gut health boosters, can help curb cravings, balance blood sugar levels, and support long-term wellness.
A new drug called amycretin has shown it can help reduce body weight in two early-phase clinical trials. The drug, which ...
Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results